[Inpatient withdrawal treatment of heroin dependence with neuroleptics--an approach to addicts].
The authors present a setting for abrupt withdrawal treatment with the following targets: 1. To facilitate the addicts the voluntary use of medical and psychiatric service. 2. To develop methods for withdrawal treatment, as riskless and easy to handle as possible. 3. To use the time of inpatient treatment for building up confidence in psychiatric services to motivate the patients for a following therapy. Drugs and dosage of peroral and intravenous neuroleptic treatment and possible complications are discussed. Peroral treatment has the advantage of lower doses, easier handling and lower complication rates. The setting and the used drugs seem to be attractive enough for many addicts to contact the clinic on their own account.
D000284:Administration, Oral; D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002749:Chlorprothixene / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006556:Heroin Dependence / Q000534:rehabilitation*; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D011352:Procyclidine / Q000627:therapeutic use; D011395:Promazine / Q000627:therapeutic use; D012114:Residential Treatment
D014150:Antipsychotic Agents; D002749:Chlorprothixene; D011352:Procyclidine; D006220:Haloperidol; D011395:Promazine
Stationäre Entzugsbehandlung bei Heroinsucht mit Neuroleptika--Ein Weg zum Süchtigen.